Are you Dr. Chan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 53 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
44 Binney Street
Suite D1 B30
Boston, MA 02115Phone+1 617-632-6922Fax+1 617-355-9092- Is this information wrong?
Summary
- Dr. Iris Chan, MD is an oncologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2000 - 2003- Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 2000
Washington University in St. Louis School of MedicineClass of 1997
Certifications & Licensure
MA State Medical License 2001 - 2024
Clinical Trials
- Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer Start of enrollment: 2002 Jun 01
- Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma Start of enrollment: 2006 Jul 01
- Taxotere + Cisplatin in Nasopharyngeal Carcinoma Start of enrollment: 2002 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 53 citationsPhase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumorsGeoffrey I. Shapiro, Patricia LoRusso, E. L. Kwak, Susan Pandya, Charles M. Rudin, Carla Kurkjian, James M. Cleary, Mary Jo Pilat, Suzanne F. Jones, Alex de Crespigny,...> ;Investigational New Drugs. 2020 Apr 1
- 33 citationsSpecific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132Jamie L. Lahvic, Michelle Ammerman, Pulin Li, Megan C. Blair, Emma R. Stillman, Eva M. Fast, Anne L. Robertson, Constantina Christodoulou, Julie R. Perlin, Song Yang, ...> ;Proceedings of the National Academy of Sciences of the United States of America. 2018 Sep 11
- 40 citationsOncogenic K-ras cooperates with PML-RARα to induce an acute promyelocytic leukemia-like diseaseIris T. Chan, Jeffery L. Kutok, Ifor R. Williams, Sarah L. Cohen, Sandra A. Moore, Hirokazu Shigematsu, Timothy J. Ley, Koichi Akashi, Michelle M. Le Beau, D. Gary Gil...> ;Blood. 2006 Sep 1
- Join now to see all
Grant Support
- Oncogenic RAS In Mouse Models Of LeukemiaNational Cancer Institute2005–2006
